Suggestions
George Toscano
President at TCG
George Toscano is the President and Founder of Toscano Consulting Group (TCG), a full-service consulting firm specializing in the pharmaceutical, biologics, and medical device industries.13 With extensive experience in the field, Toscano has established himself as a prominent figure in regulatory compliance and consulting services.
Professional Background
George Toscano has served as a project manager and expert consultant on large, complex projects.2 His expertise spans various aspects of the pharmaceutical and medical device industries, including regulatory compliance, quality assurance, and strategic consulting.
Toscano Consulting Group
Under Toscano's leadership, TCG has grown to include over 250 consultants with an average of 25 years of experience in their respective fields.1 The company offers a wide range of services, including:
- Regulatory compliance support
- Audits and assessments
- Inspection readiness
- Remediation assistance
- Regulatory submission support
- Specialized services such as toxicological assessments and expert witness testimony
Industry Recognition
Toscano's expertise is widely recognized in the industry. He has been featured in discussions about recent FDA enforcement trends, indicating his deep understanding of regulatory matters and their impact on the pharmaceutical and medical device sectors.5
Education and Location
George Toscano is based in Fort Lauderdale, Florida.24 He holds a degree from Florida Atlantic University, which he attended from 2003 to 2005.4
George Toscano's LinkedIn profile can be found under the username "georgetoscano," where more details about his professional experience and accomplishments may be available.2
Highlights
The latest insights into FDA enforcement trends for Q2 2024 are here. Key takeaways include: Increased focus on pharmaceutical quality and compliance. Stricter scrutiny on medical device cybersecurity. Enhanced regulations for dietary supplements. Dive into the full analysis on the Toscano Consulting Group blog here: https://lnkd.in/evh99-ng
The FDA has approved the first-ever treatment designed to reduce the risk of serious heart problems, particularly in adults with obesity or overweight issues. This groundbreaking approval marks a significant milestone in combating cardiovascular issues, a major concern globally. 💪❤️
Check out the article to learn more about this innovative treatment and its potential impact on improving heart health for millions of individuals:
https://lnkd.in/efJ22ri5
